Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TRHR | P34981 | 1/20 | 0.41 |
| ▸ | ACE | P12821 | 6/20 | 0.40 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | F2R | P25116 | 2/20 | 0.39 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.39 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.39 |
| ▸ | ACE2 | Q9BYF1 | 4/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29630670 | 0.94 | TRHR (0.42) | TRHRACETSHRACE2 | |
| SCHEMBL29555036 | 0.90 | ACE (0.41) | TRHRACEF2RACE2 | |
| SCHEMBL29590456 | 0.89 | TRHR (0.41) | TRHRACETSHRACE2 | |
| SCHEMBL29630526 | 0.89 | TRHR (0.41) | TRHRACETSHRACE2 | |
| SCHEMBL29701316 | 0.89 | ACE (0.49) | ACEOPRM1OPRD1ACE2 | |
| SCHEMBL30974083 | 0.88 | OPRM1 (0.42) | OPRM1OPRD1 | |
| SCHEMBL29925778 | 0.88 | ACE (0.43) | TRHRACEACE2 | |
| SCHEMBL11308630 | 0.88 | ACE (0.45) | TRHRACETSHRACE2 | |
| SCHEMBL29630560 | 0.88 | OPRK1 (0.46) | TRHRACEF2R | |
| SCHEMBL29590547 | 0.88 | OPRK1 (0.46) | TRHRACEF2R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11807899-B2 | Biochemical reaction methods and reagents comprising intrinsically disordered regions | Biocrucible Limited | 2023-11-07 | — | — | US | disclosed |
| US-20220145378-A1 | BIOCHEMICAL REACTION METHODS AND REAGENTS COMPRISING INTRINSICALLY DISORDERED REGIONS | Biocrucible Limited (GB) | 2022-05-12 | — | — | US | disclosed |